150 results
Page 2 of 8
8-K
EX-4.2
zm53ypzkthnygla4
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-10.1
yottr qi1
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-10.1
kvfrt5v5a0k8u lt
5 Jul 22
Aravive Appoints Dr. Robert B. Geller as Chief Medical Officer
7:05am
8-K
EX-10.1
0x9j0
3 Jun 22
Aravive Appoints Rudy Howard as Chief Financial Officer
4:06pm
8-K
EX-10.1
ft0t2dv98g0eknr4
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am
8-K
EX-10.2
us3e72jq3jen2hxq81
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am
424B5
k12ku cua0syws
31 Mar 22
Prospectus supplement for primary offering
6:06am
8-K
EX-10.1
7nmqw7eokccz i6
22 Mar 22
Aravive Appoints Scott Dove, Ph.D., as Chief Operating Officer
4:06pm
DEFA14A
e62oql xjsng8m2s
21 Mar 22
Additional proxy soliciting materials
4:05pm
8-K
cj4d4xnaw
21 Mar 22
Other Events
4:05pm
8-K
EX-10.1
thf 9o9k6e1v
4 Jan 22
Entry into a Material Definitive Agreement
6:02am
8-K
EX-10.1
lukbv
14 Jun 21
Entry into a Material Definitive Agreement
4:08pm